Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Jan 23, 2020 11:47am

102 Views

Post# 30589028

RE:RE:RE:RE:RE:Dr. Kamat and Keytruda 1 Year CR in NMIBC Trial

fredgoodwinson wrote: Isn`t that what they call 'damning with faint praise'?

Thought he was supposed to be on our strength? LOL

This is about as positive as he can be given his position.
He must remain impaartial until there is data to support stronger positions.
True professional imo.

Me on the other hand, I can see PDT therapy used in place of BCG in the future if the results are supportive enough. It may take another trial to get to that point but that shouldn't discourage anybody here...lol

Macer

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading